Elixxer

Elixxer AAQS

The The AAQS of Elixxer (ELXR.H.V) as of Oct 16, 2026 is 4. In the previous year, The AAQS was 4.00 — a change of 0.00% (lower).

AAQS

4

YoY

0.00%

Last updated:

Elixxer has a current AAQS of 4.

A high AAQS can be seen as a positive indicator that the company is developing successfully.

Investors can assume that the company is on a good path to generate profits.

On the other hand, it is important to consider the AAQS of the stock Elixxer in comparison to the profits generated and other companies in the same industry. A high AAQS is not an absolute guarantee for a positive future. Only in this way can one get a complete picture of the company's performance.

In order to better assess the company's development, it is important to consider the AAQS in comparison to other companies in the same industry. In general, investors should always consider the AAQS of a company in connection with other fundamentals such as profit, EBIT, cash flow, and others in order to make an informed investment decision.

The Elixxer AAQS history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

AAQS
Date
AAQS
Jan 1, 2016
4.00 CAD
Jan 1, 2017
4.00 CAD
Jan 1, 2018
4.00 CAD
Jan 1, 2019
4.00 CAD
Jan 1, 2020
4.00 CAD
Jan 1, 2021
4.00 CAD
Jan 1, 2022
4.00 CAD
Jan 1, 2023
4.00 CAD
The Elixxer AAQS history
YEARAAQSYoY
40.00%
40.00%
40.00%
40.00%
40.00%
40.00%
40.00%
40.00%
40.00%
4—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Elixxer Stock analysis

What does Elixxer do? Elixxer Ltd, trading under the ticker ELXR.H.V and registered with ISIN CA28660W20004, is a company based in Montreal, Canada. It operates within the Financial Services sector, specifically in the Financials industry. The company completed its initial public offering on November 24, 2005. Elixxer Ltd maintains a website at https://www.elixxer.com/. The company's primary focus involves investments in cannabis-related businesses, including entities licensed for the cultivation, production, and sale of cannabis and cannabis-derived products. Its investment portfolio spans various segments of the cannabis industry, such as nutraceuticals, cosmetics, pharmaceuticals, cultivation, and extraction. The firm emphasizes medical cannabis and specialty cannabis-derived products within the pharmaceutical sector. Elixxer Ltd also engages in the cultivation and production of medical-grade cannabis for global markets. Additionally, the company develops and produces Cannabidiol (CBD) cosmetics and natural wellness products. It invests in facilities dedicated to the cultivation, extraction, and production of legal cannabis products. The company's brands include Viridi, Easyjoint, Freia, Little Green Pharma (LGP), and One Premium Cannabis. Elixxer Ltd holds investments in cannabis companies across multiple countries, including Australia, Canada, Switzerland, Italy, and Jamaica. Subsidiaries of the company include LGC Finance Limited, LGC Capital EU OU, and LGC Capital Spain S.L. Elixxer is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Elixxer stock

The AAQS of Elixxer is 4 in 2023.

On Eulerpool you can find the complete historical development of The AAQS Elixxer since 2006 – with annual values, charts, and detailed analysis.

The AAQS is a key figure developed by AlleAktien.

The AAQS is a key figure developed by AlleAktien.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Quality — Elixxer

All Key Metrics — Elixxer